Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;9(1):45–54. doi: 10.1111/j.1750-3639.1999.tb00209.x

Co‐Localization of TSC1 and TSC2 Gene Products in Tubers of Patients with Tuberous Sclerosis

Michael W Johnson 1, Jessica K Emelin 1, Sung‐Hye Park 1, Harry v Vinters 1,2,✉
PMCID: PMC8098249  PMID: 9989450

Abstract

Two genes, mutations in which result in the phenotype of tuberous sclerosis (TSC), have recently been cloned. TSC2 on chromosome 16p 13.3 encodes the protein tuberin, which appears to have growth regulating properties. TSC1 on chromosome 9q34 encodes hamartin which, as yet, has no specified cellular functions. Polyclonal antibodies were raised to synthetic peptides representing portions of tuberin and hamartin and used in immunoblots and immunohistochemical studies to localize the proteins in surgically resected neocortical tubers from four TSC patients. On Western blots of autopsy brain specimens, K‐562 cell, and NT2 lysates, each antibody labelled a single band at the expected molecular weight. In immunohistochemical protocols on paraffin embedded tissue, antibodies to both tuberin and hamartin prominently labelled atypical and dysmorphic neuroglial cells that are a defining feature of TSC tubers. Some abnormal cells within cortical tuber sections were labelled with both tuberin and hamartin antisera. Our results suggest that tuberin and hamartin are both robustly expressed in similar populations of neuroglial cells of TSC tubers, even in the presence of TSC1 or TSC2 germline mutations. The roles of these gene products in normal and abnormal cortical development, tuber pathogenesis and the generation of seizures remain to be defined.

Full Text

The Full Text of this article is available as a PDF (190.3 KB).

References

  • 1. Au K‐S, Rodriguez JA, Finch JL, Volcik KA, Roach ES, Delgado MR, Rodriguez E Jr, Northrup H (1998) Germ‐line mutational analysis of the TSC2 gene in 90 tuberous‐sclerosis patients. Am J Hum Genet 62:286–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Carbonara C, Longa L, Grosso E, Borrone C, Garrè MG, Brisigotti M, Migone N (1994) 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor‐like activity also for the TSC1 gene. Hum Mol Genet 3: 1829–1832. [DOI] [PubMed] [Google Scholar]
  • 3. Crino PB, Eberwine J (1997) Cellular and molecular basis of cerebral dysgenesis. J Neurosci Res 50:907–916. [DOI] [PubMed] [Google Scholar]
  • 4. Crino PB, Trojanowski JQ, Dichter MA, Eberwine J (1996) Embryonic neuronal markers in tuberous sclerosis: Single‐cell molecular pathology. Proc Natl Acad Sci USA 93: 14152–14157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Eichmuller S, Stevenson PA, Paus R (1996) A new method for double immunolabelling with primary antibodies from identical species. J Immunol Methods 190:255–265. [DOI] [PubMed] [Google Scholar]
  • 6. The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305–1315. [DOI] [PubMed] [Google Scholar]
  • 7. Farrell MA, DeRosa MJ, Curran JG, Secor DL, Cornford ME, Comair YG, Peacock WJ, Shields WD, Vinters HV (1992) Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy. Acta Neuropathol 83:246–259. [DOI] [PubMed] [Google Scholar]
  • 8. Geist RT, Gutmann DH (1995) The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differ 6: 1477–1483. [PubMed] [Google Scholar]
  • 9. Geist RT, Reddy AJ, Zhang J, Gutmann DH (1996) Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues. Neurobiol Disease 3: 111–120. [DOI] [PubMed] [Google Scholar]
  • 10. Goldman SA, Luskin MB (1998) Strategies utilized by migrating neurons of the postnatal vertebrate forebrain. Trends Neurosci 21: 107–114. [DOI] [PubMed] [Google Scholar]
  • 11. Gomez MR (1988) Tuberous Sclerosis, Second edition. New York : Raven Press. [Google Scholar]
  • 12. Gomez MR (1991) Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann NY Acad Sci 615: 1–7. [DOI] [PubMed] [Google Scholar]
  • 13. Goodman M, Lamm SH, Engel A, Shepherd CW, Houser OW, Gomez MR (1997) Cortical tuber count: A biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol 12:85–90. [DOI] [PubMed] [Google Scholar]
  • 14. Green AJ, Johnson PH, Yates JRW (1994) The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 3: 1833–1834. [DOI] [PubMed] [Google Scholar]
  • 15. Green AJ, Smith M, Yates JRW (1994) Loss of heterozy‐gosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genetics 6: 193–196. [DOI] [PubMed] [Google Scholar]
  • 16. Grimes ML, Zhou J, Beattie EC, Yuen EC, Hall DE, Valletta JS, Topp KS, LaVail JH, Bunnett NW, Mobley WC (1996) Endocytosis of activated TrkA: Evidence that nerve growth factor induces formation of signaling endosomes. J Neurosci 16:7950–7964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Henske EP, Scheithauer BW, Short MR Wollmann R, Nahmias J, Hornigold N, Van Slegtenhorst M, Welsh CT, Kwiatkowski DJ (1996) Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59:400–406. [PMC free article] [PubMed] [Google Scholar]
  • 18. Henske EP, Wessner LL, Golden J, Scheithauer BW, Vortmeyer AO, Zhuang Z, Klein‐Szanto AJP, Kwiatkowski DJ, Yeung RS (1997) Loss of tuberin in both subependy‐mal giant cell astrocytomas and angiomyolipomas supports a two‐hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol 151: 1639–1647. [PMC free article] [PubMed] [Google Scholar]
  • 19. Kerfoot C, Wienecke R, Menchine M, Emelin J, Maize JC Jr, Welsh CT, Norman MG, DeClue JE, Vinters HV (1996) Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol 6:367–377. [DOI] [PubMed] [Google Scholar]
  • 20. Kimura N, Watanabe M, Date F, Kitamoto T, Kimura I, Horii A, Nagura H (1997) HMB‐45 and tuberin in hamartomas associated with tuberous sclerosis. Mod Pathol 10:952–959. [PubMed] [Google Scholar]
  • 21. Luskin MB (1994) Neuronal cell lineage in the vertebrate central nervous system. FASEB J 8:122–130. [DOI] [PubMed] [Google Scholar]
  • 22. Menchine M, Emelin JK, Mischel PS, Haag TA, Norman MG, Pepkowitz SH, Welsh CT, Townsend JJ, Vinters HV (1996) Tissue and cell‐type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod Pathol 9:1071–1080. [PubMed] [Google Scholar]
  • 23. Mischel PS, Nguyen LP, Vinters HV (1995) Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54: 137–153. [DOI] [PubMed] [Google Scholar]
  • 24. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S (1996) Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol 40:941–944. [DOI] [PubMed] [Google Scholar]
  • 25. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S (1997) Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol 94:525–531. [DOI] [PubMed] [Google Scholar]
  • 26. Park S‐H, Emelin J, Vinters HV (1998) Tuberin (TSC2) and hamartin (TSC1) expression in human fetal and child brains. J Neuropathol Exp Neurol 57:515. [Google Scholar]
  • 27. Park S‐H, Pepkowitz SH, Kerfoot C, De Rosa MJ, Poukens V, Wienecke R, DeClue JE, Vinters HV (1997) Tuberous sclerosis in a 20‐week gestation fetus: immunohistochemical study. Acta Neuropathol 94: 180–186. [DOI] [PubMed] [Google Scholar]
  • 28. Peacock WJ, Wehby‐Grant MC, Shields WD, Shewmon DA, Chugani HT, Sankar R, Vinters HV (1996) Hemispherectomy for intractable seizures in children: a report of 58 cases. Child's Nerv Syst 12:376–384. [DOI] [PubMed] [Google Scholar]
  • 29. Richardson EP Jr (1991) Pathology of tuberous sclerosis. Neuropathologic aspects. Ann NY Acad Sci 615: 128–139. [DOI] [PubMed] [Google Scholar]
  • 30. Sampson JR, Harris PC (1994) The molecular genetics of tuberous sclerosis. Hum Mol Genet 3: 1477–1480. [DOI] [PubMed] [Google Scholar]
  • 31. Van Slegtenhorst M, De Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MR Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JBM, Ward S, Green AJ, Yates JRW, Kwiatkowska J, Henske EP, Short MR Haines JH, Jozwiak S, Kwiatkowski DJ (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808. [DOI] [PubMed] [Google Scholar]
  • 32. Van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson J, Hally D, van der Sluijs P (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7: 1053–1057. [DOI] [PubMed] [Google Scholar]
  • 33. Vinters HV, De Rosa MJ, Farrell MA (1993) Neuropathologic study of resected cerebral tissue from patients with infantile spasms. Epilepsia 34:772–779. [DOI] [PubMed] [Google Scholar]
  • 34. Vinters HV, Kerfoot C, Catania M, Emelin JK, Roper SN, DeClue JE (1998) Tuberous sclerosis‐related gene expression in normal and dysplastic brain. Epilepsy Res 32: 12–23. [DOI] [PubMed] [Google Scholar]
  • 35. Vinters HV, Kerfoot C, Emelin JK (1997) Tuberin loss from cerebral tissues. Ann Neurol 42:270–271. [DOI] [PubMed] [Google Scholar]
  • 36. Wienecke R, Guha A, Maize JC Jr, Heideman RL, DeClue JE, Gutmann DH (1997) Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas. Ann Neurol 42:230–235. [DOI] [PubMed] [Google Scholar]
  • 37. Wienecke R, König A, DeClue JE (1995) Identification of tuberin, the tuberous sclerosis‐2 product. Tuberin possesses specific Rap 1 GAP activity. J Biol Chem 270: 16409–16414. [DOI] [PubMed] [Google Scholar]
  • 38. Wienecke R, Maize JC Jr, Reed JA, De Gunzburg J, Yeung RS, DeClue JE (1997) Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 150:43–50. [PMC free article] [PubMed] [Google Scholar]
  • 39. Wilson PJ, Ramesh V, Kristiansen A, Bove C, Jozwiak S, Kwiatkowski DJ, Short MR Haines JL (1996) Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum Mol Genet 5:249–256. [DOI] [PubMed] [Google Scholar]
  • 40. Xiao G‐H, Shoarinejad F, Jin F, Golemis EA, Yeung RS (1997) The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 272:6097–6100. [DOI] [PubMed] [Google Scholar]
  • 41. Yeung RS, Katsetos CD, Klein‐Szanto A (1997) Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 151: 1477–1486. [PMC free article] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES